Multi-Organ Dysfunction Syndrome (MODS) Pathology

Quick Answer

Clinical Note

Multi-Organ Dysfunction Syndrome (MODS) is the progressive, potentially reversible dysfunction of two or more organ systems arising from an acute threat to systemic homeostasis. MODS represents the final common pathway of critical illness, whether initiated by sepsis, trauma, burns, pancreatitis, or major surgery. The pathophysiology involves a dysregulated host response leading to systemic inflammation, endothelial dysfunction, glycocalyx degradation, microcirculatory failure, mitochondrial dysfunction, and immune dysregulation. The SOFA score quantifies organ dysfunction across six systems (respiratory, cardiovascular, hepatic, coagulation, renal, neurological), with each point increase associated with approximately 10% increase in mortality. Organ cross-talk (gut-lung axis, cardiorenal syndrome, brain-heart interaction) amplifies injury. The "gut hypothesis" proposes that intestinal barrier failure permits bacterial translocation and PAMP release, perpetuating systemic inflammation. Recovery depends on restoration of mitochondrial function and resolution of the persistent inflammation-immunosuppression-catabolism syndrome (PICS).

CICM Exam Focus

Clinical Note

SAQ Topics (First Part Written)

Define MODS and distinguish primary from secondary MODS
Describe the SOFA score, its components, and correlation with mortality
Explain the pathophysiology of organ cross-talk in MODS (gut-lung axis, cardiorenal syndrome)
Describe the "gut hypothesis" and mechanisms of bacterial translocation
Explain microcirculatory dysfunction in MODS
Describe the progression from SIRS to CARS to PICS and its clinical implications
Compare and contrast the pathophysiology of individual organ failures in MODS

Viva Topics

The unifying pathophysiology of MODS: inflammation, endothelium, microcirculation, mitochondria
Organ cross-talk mechanisms and clinical implications
Cellular hibernation hypothesis and the "MODS paradox"
PICS and chronic critical illness: long-term outcomes
Biomarkers for MODS prognostication
Histopathological findings in MODS autopsy

Common Examiner Questions

"What is the difference between primary and secondary MODS?"
"Explain how gut barrier failure contributes to MODS"
"Describe the SOFA score and its prognostic value"
"What is organ cross-talk? Give examples"
"Why do organs fail functionally despite minimal histological damage?"
"What is PICS and how does it affect ICU survivors?"

Key Points

Clinical Note

MODS is defined as the development of potentially reversible physiological dysfunction in two or more organ systems that arises from an acute threat to systemic homeostasis. Primary MODS results from direct insult (e.g., lung contusion causing ARDS), while secondary MODS develops as a consequence of the host inflammatory response to an initial insult (PMID: 1597163).

Clinical Note

The Sequential Organ Failure Assessment (SOFA) score evaluates dysfunction in six organ systems: respiratory (PaO2/FiO2), coagulation (platelets), hepatic (bilirubin), cardiovascular (MAP/vasopressors), neurological (GCS), and renal (creatinine/urine output). A SOFA score ≥2 defines organ dysfunction, and each 1-point increase is associated with approximately 10% increase in mortality (PMID: 8844239).

Clinical Note

MODS results from a dysregulated host response characterised by excessive pro-inflammatory cytokine release (TNF-α, IL-1β, IL-6), followed by compensatory anti-inflammatory response (IL-10, TGF-β). This imbalance leads to both hyperinflammation and immunoparalysis, creating conditions for organ injury and secondary infections (PMID: 12519925).

Clinical Note

The endothelial glycocalyx (proteoglycans, GAGs) is degraded by inflammatory mediators (heparanase, MMPs, ROS), leading to increased vascular permeability (capillary leak), exposure of adhesion molecules (leukocyte recruitment), loss of anticoagulant surface (microthrombosis), and impaired vasomotor regulation (PMID: 30654825).

Clinical Note

MODS is characterised by microcirculatory dysfunction with heterogeneous capillary flow, functional shunting, and decreased oxygen extraction despite adequate macrocirculatory parameters. Sublingual microcirculation can be assessed by sidestream dark-field (SDF) imaging. Microcirculatory dysfunction predicts mortality independent of macrocirculation (PMID: 17452929).

Clinical Note

The gastrointestinal tract is proposed as the "motor" of MODS. Critical illness causes intestinal barrier failure (tight junction disruption, enterocyte apoptosis), bacterial translocation, and release of PAMPs (LPS, peptidoglycan) and DAMPs into the portal and systemic circulation, perpetuating systemic inflammation even after the initial insult resolves (PMID: 3539903).

Clinical Note

Organ systems interact bidirectionally in MODS. Examples include: gut-lung axis (intestinal inflammation primes pulmonary neutrophils), cardiorenal syndrome (cardiac dysfunction causes renal congestion and vice versa), hepatorenal syndrome, and brain-heart interaction (autonomic dysregulation). Injury to one organ propagates dysfunction in distant organs (PMID: 24988057).

Clinical Note

Mitochondria fail to utilise oxygen despite adequate delivery ("cytopathic hypoxia"). Mechanisms include NO-mediated Complex IV inhibition, oxidative damage to ETC components, and metabolic reprogramming. Cells enter "hibernation" to survive, explaining organ dysfunction without necrosis (PMID: 12594860).

Clinical Note

The immune response evolves from initial hyperinflammation (SIRS) to immunosuppression (CARS) to Persistent Inflammation-Immunosuppression-Catabolism Syndrome (PICS). PICS is characterised by ongoing low-grade inflammation, immunoparalysis, and protein catabolism, leading to chronic critical illness with poor long-term outcomes (PMID: 22710073).

Clinical Note

Autopsy studies show surprisingly minimal histological damage despite profound clinical organ dysfunction. This supports "cellular hibernation"

organs fail functionally through metabolic shutdown rather than necrosis, explaining potential for recovery if patients survive the acute phase (PMID: 12225604).

Definition and Classification

Historical Evolution

The concept of MODS evolved from observations in the 1970s-1980s that critically ill patients developed a syndrome of progressive organ failures distinct from the primary insult (PMID: 6827997).

Clinical Note

Term	Era	Description
Multiple Organ Failure (MOF)	1970s	Original description by Baue, Tilney
Multiple Systems Organ Failure (MSOF)	1980s	Fry's description emphasising systemic nature
Sequential System Failure	1980s	Emphasised temporal progression
Multi-Organ Dysfunction Syndrome (MODS)	1991	ACCP/SCCM Consensus Conference - preferred term

Current Definition

MODS is defined as "the development of potentially reversible physiological dysfunction in two or more organ systems that arises from an acute threat to systemic homeostasis" (PMID: 1597163).

Key aspects of this definition:

Potentially reversible: Distinguishes from permanent organ failure
Physiological dysfunction: Function is impaired, not necessarily structure
Two or more systems: Defines multi-organ involvement
Acute threat: Distinguishes from chronic organ dysfunction
Systemic homeostasis: Emphasises whole-body dysregulation

Primary vs Secondary MODS

Clinical Note

Primary MODS

Results from a direct insult to the organ(s)
Organ dysfunction is directly attributable to the initiating event
Occurs early (within 72 hours of insult)
Examples:
- ARDS from pulmonary contusion (trauma)
- AKI from crush injury myoglobinuria
- Hepatic failure from paracetamol overdose
- Myocardial dysfunction from myocardial infarction

Secondary MODS

Results from the host inflammatory response to an insult
Not directly caused by the primary event
Occurs later (typically 5-7 days post-insult)
Represents dysregulated systemic inflammation affecting remote organs
Examples:
- ARDS developing after severe pancreatitis
- AKI in sepsis without nephrotoxic agents
- Hepatic dysfunction in pneumonia

Two-Hit Hypothesis

The "two-hit" or "multiple-hit" hypothesis explains why some patients develop secondary MODS (PMID: 9343125):

First Hit: Initial insult (trauma, surgery, infection) primes the inflammatory system
Primed State: Systemic inflammatory mediators and activated immune cells circulate
Second Hit: A subsequent insult (infection, hypoperfusion, transfusion) triggers an exaggerated inflammatory response
MODS: The amplified response leads to secondary organ dysfunction

Clinical Pearl

This explains why patients with seemingly "minor" secondary insults (e.g., low-grade infection, minor procedure) can develop catastrophic MODS if they are in a "primed" inflammatory state. It underscores the importance of avoiding unnecessary second hits (nosocomial infections, unnecessary interventions, blood transfusions) in at-risk patients.

The SOFA Score

Development and Validation

The Sequential Organ Failure Assessment (SOFA) score was developed by the European Society of Intensive Care Medicine working group in 1994 and validated in 1996 (PMID: 8844239).

Original purpose: To quantify organ dysfunction over time, not to predict mortality Current use: Diagnostic criterion for sepsis (Sepsis-3), prognostication, clinical trials

SOFA Score Components

Clinical Note

System	Score 0	Score 1	Score 2	Score 3	Score 4
Respiration (PaO₂/FiO₂, mmHg)	≥400	<400	<300	<200 with respiratory support	<100 with respiratory support
Coagulation (Platelets ×10³/μL)	≥150	<150	<100	<50	<20
Liver (Bilirubin μmol/L)	<20	20-32	33-101	102-204	>204
Cardiovascular	MAP ≥70 mmHg	MAP <70 mmHg	Dopamine ≤5 or dobutamine (any)	Dopamine >5 or Adr/NA ≤0.1	Dopamine >15 or Adr/NA >0.1
CNS (Glasgow Coma Scale)	15	13-14	10-12	6-9	<6
Renal (Creatinine μmol/L or UO)	<110	110-170	171-299	300-440 or UO <500 mL/day	>440 or UO <200 mL/day

Maximum score: 24 (4 points × 6 systems) Note: Vasopressor doses in μg/kg/min

SOFA Score Interpretation

SOFA Score	Approximate Mortality	Interpretation
0-6	<10%	Mild organ dysfunction
7-9	15-20%	Moderate organ dysfunction
10-12	40-50%	Severe organ dysfunction
13-14	50-60%	Very severe dysfunction
≥15	>80%	Critical dysfunction

Delta SOFA and Trends

Clinical Pearl

The change in SOFA score over time (ΔSOFA) is more prognostically valuable than absolute SOFA score:

SOFA increase ≥2 points in 48-72 hours: Defines sepsis-related organ dysfunction (Sepsis-3)
Non-improvement or increase at 48-72 hours: Associated with poor outcome
SOFA decrease >2 points in first 48-72 hours: Associated with improved survival

Serial SOFA measurements should guide escalation or de-escalation decisions (PMID: 11445675).

Number of Failing Organs and Mortality

Number of Failing Organs	ICU Mortality
0	<5%
1	20-30%
2	40-50%
3	60-70%
4+	>80%

Duration of organ failure also matters: Mortality increases with each additional day of MODS.

Pathophysiology Overview

Unifying Mechanisms

MODS develops through interconnected pathophysiological cascades that amplify each other:

Initial Insult (Sepsis, Trauma, Burns, Pancreatitis)
         ↓
    PAMP / DAMP Release
         ↓
    Pattern Recognition Receptor Activation (TLRs, NLRs)
         ↓
    Cytokine Storm (TNF-α, IL-1β, IL-6)
         ↓
┌────────────────────────────────────────────────────┐
│                                                    │
↓                    ↓                   ↓           ↓
Endothelial      Coagulation      Immune        Metabolic
Dysfunction      Activation     Dysregulation   Failure
    ↓                ↓              ↓              ↓
Capillary Leak   DIC / Micro-   SIRS → CARS   Mitochondrial
Glycocalyx Loss  thrombosis                   Dysfunction
                     ↓              ↓              ↓
                     └──────────────┼──────────────┘
                                    ↓
                    MICROCIRCULATORY FAILURE
                                    ↓
                    Tissue Hypoxia / Dysoxia
                                    ↓
                    ORGAN DYSFUNCTION (MODS)
                                    ↓
              ┌─────────────────────┼─────────────────────┐
              ↓                     ↓                     ↓
         Recovery              PICS/CCI              Death
    (Mitochondrial           (Chronic             (Refractory
     Biogenesis)           Critical Illness)        MODS)

The Four Pillars of MODS Pathophysiology

Systemic Inflammation: Dysregulated host response with cytokine imbalance
Endothelial Dysfunction: Glycocalyx degradation, barrier failure, pro-coagulant state
Microcirculatory Failure: Heterogeneous flow, shunting, oxygen extraction defect
Mitochondrial Dysfunction: Bioenergetic failure, cytopathic hypoxia

Organ Cross-Talk

The Concept of Organ Cross-Talk

Organ cross-talk refers to the bidirectional communication between organ systems whereby dysfunction in one organ leads to dysfunction in distant organs (PMID: 24988057). This occurs through:

Humoral mediators: Cytokines, hormones, metabolites
Immune cell trafficking: Activated neutrophils, monocytes
Neural pathways: Autonomic nervous system
Haemodynamic effects: Pressure/flow alterations
Microvesicles/exosomes: Intercellular communication

Gut-Lung Axis

The gut-lung axis is one of the best-characterised organ cross-talk pathways in MODS (PMID: 28257560):

Clinical Note

Gut → Lung:

Intestinal barrier failure → bacterial/PAMP translocation to mesenteric lymph
Mesenteric lymph (NOT portal blood) carries gut-derived factors to pulmonary circulation
Activated neutrophils in gut mucosa recirculate to lungs
Gut-derived cytokines prime pulmonary endothelium
Result: ARDS following intestinal ischaemia, pancreatitis, or trauma

Lung → Gut:

ARDS causes systemic cytokine release
Mechanical ventilation induces systemic inflammation (biotrauma)
Hypoxaemia and systemic inflammation cause intestinal hypoperfusion
Result: Stress ulceration, ileus, bacterial overgrowth

Cardiorenal Syndrome

Cardiorenal syndrome describes the bidirectional interaction between heart and kidney failure (PMID: 18802999):

Type	Direction	Mechanism
Type 1	Acute Heart → Acute Kidney	Cardiogenic shock → renal hypoperfusion
Type 2	Chronic Heart → Chronic Kidney	CHF → chronic renal congestion/hypoperfusion
Type 3	Acute Kidney → Acute Heart	AKI → fluid overload, uraemia, arrhythmia
Type 4	Chronic Kidney → Chronic Heart	CKD → LVH, accelerated atherosclerosis
Type 5	Systemic → Both	Sepsis, diabetes, amyloidosis affecting both

Key mechanisms:

Renal venous congestion (elevated CVP reduces renal perfusion pressure)
Neurohormonal activation (RAAS, SNS)
Inflammation and oxidative stress
Uraemic toxin accumulation

Clinical Pearl

In cardiorenal syndrome, elevated CVP is a stronger predictor of AKI than reduced cardiac output. Renal venous congestion impairs the kidney's ability to maintain GFR even with adequate arterial pressure. This explains why diuresis (reducing venous congestion) can paradoxically improve renal function in heart failure.

Hepatorenal Syndrome

Hepatorenal syndrome (HRS) is functional renal failure in advanced liver disease (PMID: 27842565):

Pathophysiology:

Portal hypertension → splanchnic vasodilation (NO-mediated)
Effective arterial hypovolaemia
Compensatory renal vasoconstriction (RAAS, SNS, ADH)
Renal cortical hypoperfusion
Prerenal AKI progressing to ATN

Types:

HRS-AKI (Type 1): Rapid deterioration, often precipitated by infection
HRS-CKD (Type 2): Gradual decline, associated with refractory ascites

Brain-Heart Interaction

The brain and heart interact through autonomic and humoral pathways (PMID: 31124428):

Brain → Heart:

Subarachnoid haemorrhage → stress cardiomyopathy (Takotsubo-like)
Catecholamine surge → myocardial stunning, arrhythmias
Autonomic dysregulation → QT prolongation, Torsades de Pointes
Neurogenic pulmonary oedema (hypothalamic-mediated)

Heart → Brain:

Cardiac arrest → hypoxic-ischaemic brain injury
Low cardiac output → cerebral hypoperfusion
Cardiac surgery → stroke, delirium
AF → embolic stroke

Lung-Brain Axis

Clinical Note

Lung → Brain:

ARDS → systemic inflammation → neuroinflammation
Mechanical ventilation → biotrauma → delirium
Hypoxaemia/hypercapnia → cognitive impairment
Liberation from mechanical ventilation improves cognition

Brain → Lung:

Neurogenic pulmonary oedema (massive sympathetic discharge)
Aspiration pneumonia (impaired airway protection)
Central hypoventilation syndromes
Brain death → donor lung injury (catecholamine storm)

The Gut Hypothesis

Origins and Evolution

The "gut hypothesis" was proposed by Meakins and Marshall in 1986, suggesting that the gastrointestinal tract is the "motor" of MODS (PMID: 3539903). This revolutionised understanding of MODS pathophysiology.

Clinical Note

Core Concept: The gut, under conditions of critical illness, becomes a source of inflammatory mediators and bacteria/endotoxins that perpetuate systemic inflammation and drive MODS progression - even after the initial insult is controlled.

The gut acts as:

Largest immune organ: 70-80% of body's immune cells
Largest endocrine organ: Massive cytokine production capacity
Barrier organ: Separating 10^14 bacteria from sterile body
Reservoir of PAMPs: LPS, peptidoglycan, flagellin

Mechanisms of Gut Barrier Failure

The intestinal barrier is a multi-layered defence system that fails in critical illness (PMID: 27350294):

1. Epithelial Barrier

Normal structure:

Single layer of columnar epithelium
Tight junctions (claudins, occludin, ZO-1)
Adherens junctions (E-cadherin, catenins)
Mucus layer (goblet cell-derived)

Failure mechanisms:

Enterocyte apoptosis (TNF-α, Fas/FasL, ischaemia)
Tight junction disruption (cytokines, hypoxia, oxidative stress)
Mucus layer degradation (bacterial enzymes, reduced secretion)
Villous atrophy (reduced enterocyte proliferation)

2. Immunological Barrier

Normal components:

Secretory IgA (sIgA)
Paneth cell antimicrobial peptides (defensins, lysozyme)
Intraepithelial lymphocytes
Lamina propria immune cells

Failure mechanisms:

Reduced sIgA secretion in critical illness
Paneth cell dysfunction
Immunoparalysis affecting gut-associated lymphoid tissue (GALT)

3. Microbiological Barrier

Normal commensal flora provides colonisation resistance:

Bacteroides, Lactobacillus, Bifidobacterium predominate
Produce short-chain fatty acids (butyrate)
Compete with pathogens for nutrients and adhesion sites

Dysbiosis in critical illness:

Loss of beneficial anaerobes
Overgrowth of pathogenic bacteria (Enterobacteriaceae, Pseudomonas)
Candida overgrowth
Reduced microbial diversity ("pathobiome")

Bacterial Translocation

Bacterial translocation is defined as the passage of viable bacteria or bacterial products from the gut lumen to normally sterile tissues (PMID: 7930568):

Routes of translocation:

Paracellular: Through disrupted tight junctions
Transcellular: Via M cells and enterocytes
Lymphatic: To mesenteric lymph nodes and beyond

Destination of translocated material:

Route	Destination	Consequence
Portal vein	Liver (Kupffer cells)	Hepatic inflammation, clearance failure
Mesenteric lymph	Thoracic duct → pulmonary circulation	Lung injury (ARDS)
Systemic	Multiple organs	MODS

Clinical Pearl

A paradigm shift occurred when Deitch demonstrated that mesenteric lymph, NOT portal blood, is the primary route by which gut-derived factors cause lung injury. Ligation of the mesenteric lymph duct prevents ARDS in experimental models, even when portal blood flow is maintained. This explains why liver failure (which should clear portal toxins) does not prevent gut-derived MODS (PMID: 16960241).

PAMPs and Endotoxaemia

Lipopolysaccharide (LPS/Endotoxin):

Major component of Gram-negative bacterial outer membrane
Detected in systemic circulation in 70-80% of critically ill patients
Levels correlate with illness severity and outcome
Activates TLR4 → NF-κB → cytokine production

Other gut-derived PAMPs:

Peptidoglycan (Gram-positive bacteria)
Flagellin
Bacterial DNA (CpG motifs)
Lipoteichoic acid

Clinical Evidence for Gut Hypothesis

Evidence	Finding
Endotoxaemia	Present in 70-80% of critically ill patients (PMID: 7678609)
Bacterial translocation	Demonstrated in trauma, burns, shock models
Mesenteric lymph toxicity	Lymph from shocked animals causes lung injury
Intestinal permeability	Increased in ICU patients (lactulose-mannitol test)
Dysbiosis	Correlates with MODS severity
Selective digestive decontamination	Reduces mortality in some trials (PMID: 19641363)

Endothelial Activation and Dysfunction

The Endothelium as a Target and Effector Organ

The vascular endothelium comprises 1-6 × 10^13 cells, covering ~4,000-7,000 m² surface area. In MODS, the endothelium transitions from a quiescent, anti-inflammatory, anti-coagulant state to an activated, pro-inflammatory, pro-coagulant phenotype (PMID: 30654825).

Endothelial Glycocalyx

The glycocalyx is a 0.5-4.5 μm carbohydrate-rich layer lining all blood vessels:

Composition:

Component	Examples	Function
Proteoglycans	Syndecans (1-4), Glypicans	Core proteins with GAG attachment
Glycosaminoglycans	Heparan sulfate (50-90%), Chondroitin sulfate, Hyaluronan	Molecular sieve, signalling
Glycoproteins	Selectins, Integrins, IgG superfamily	Adhesion, signalling
Plasma proteins	Albumin, Antithrombin III	Oncotic pressure, anticoagulation

Normal functions:

Permeability barrier: Molecular sieve excluding albumin
Mechanotransduction: Shear stress sensing → eNOS activation → NO production
Anti-thrombotic: Binds antithrombin III, masks pro-coagulant surfaces
Anti-inflammatory: Shields adhesion molecules (ICAM-1, VCAM-1, E-selectin)
Signalling reservoir: Stores growth factors, enzymes

Glycocalyx Degradation in MODS

Sheddases (degrading enzymes):

Enzyme	Target	Activator
Heparanase-1	Heparan sulfate	TNF-α, IL-1β, ROS
MMPs (MMP-2, -9)	Proteoglycan core proteins	Cytokines, activated leukocytes
ADAM17 (TACE)	Syndecan-1, -4	TNF-α
Hyaluronidases	Hyaluronan	Inflammatory mediators

Reactive oxygen species: Direct oxidative cleavage of GAG chains

Consequences of Glycocalyx Degradation

Red Flag

1. Capillary Leak Syndrome

Loss of oncotic barrier → albumin extravasation
Interstitial oedema despite intravascular hypovolaemia
Contributes to refractory hypotension
Explains "third-spacing" in critical illness

2. Leukocyte Adhesion

Exposed adhesion molecules (ICAM-1, VCAM-1, E-selectin)
Neutrophil tethering, rolling, firm adhesion
Transendothelial migration
Tissue infiltration and damage

3. Microvascular Thrombosis

Loss of antithrombin binding sites
Exposed tissue factor
Platelet adhesion
Contributes to DIC

4. Impaired Vasoregulation

Loss of shear stress sensing
Reduced NO production
Contributes to "vasoplegia"

Biomarkers of Glycocalyx Degradation

Biomarker	Clinical Significance
Syndecan-1	Most studied; elevated levels predict AKI, ARDS, mortality (PMID: 30654825)
Heparan sulfate	Associated with septic encephalopathy
Hyaluronan	Reflects degradation severity
Soluble thrombomodulin	Endothelial damage marker

Adhesion Molecule Expression

Selectins (initial tethering/rolling):

E-selectin (endothelium)
P-selectin (endothelium, platelets)

Immunoglobulin superfamily (firm adhesion):

ICAM-1 (Intercellular Adhesion Molecule-1)
VCAM-1 (Vascular Cell Adhesion Molecule-1)

Integrins (leukocyte side):

LFA-1 (binds ICAM-1)
VLA-4 (binds VCAM-1)

Clinical relevance: Adhesion molecule levels correlate with MODS severity

Microcirculation in MODS

Normal Microcirculation

The microcirculation comprises vessels <100 μm diameter (arterioles, capillaries, venules) and is the site of oxygen/nutrient delivery and waste removal.

Normal characteristics:

Homogeneous capillary flow
Continuous RBC flow in all capillaries
Functional capillary density (FCD): 10-12 mm/mm²
Haemoglobin oxygen diffusion distance: <70 μm

Microcirculatory Dysfunction in MODS

Clinical Note

Key abnormalities (PMID: 17452929):

Heterogeneous flow distribution:
- Some capillaries: high flow (hyperaemic)
- Adjacent capillaries: low/no flow (ischaemic)
- Creates diffusion limitation and functional shunting
Reduced functional capillary density (FCD):
- Normal: 10-12 mm/mm²
- MODS: often <6 mm/mm²
- Fewer perfused capillaries = increased diffusion distance
Increased proportion of intermittent/stopped flow:
- Normal: <5% stopped capillaries
- MODS: >20-40% stopped or intermittent
Impaired oxygen extraction:
- Despite adequate macrocirculation (CO, MAP)
- ScvO₂ may be normal or elevated despite tissue hypoxia

Mechanisms of Microcirculatory Dysfunction

Mechanism	Description
Endothelial dysfunction	Loss of autoregulation, NO depletion
Glycocalyx loss	Increased leukocyte adhesion, obstruction
Microthrombosis	DIC-related fibrin plugging
RBC deformability	Reduced RBC flexibility → capillary plugging
Leukocyte adhesion	Activated neutrophils block capillaries
Oedema	Increased diffusion distance
Vasoplegia	Loss of arteriolar tone regulation

Assessment of Microcirculation

Sublingual microcirculation:

Assessed using sidestream dark-field (SDF) or incident dark-field (IDF) imaging
Sublingual mucosa represents splanchnic microcirculation
Parameters measured: MFI, PPV, TVD, heterogeneity index

Parameter	Full Name	Description
MFI	Microcirculatory Flow Index	Semiquantitative flow score (0-3)
PPV	Proportion of Perfused Vessels	% vessels with continuous flow
TVD	Total Vessel Density	Vessel length per area
De Backer score	Vessel density × % perfused	Functional capillary density

Microcirculation-Macrocirculation Dissociation

Clinical Pearl

A key insight in MODS is that normalisation of macrocirculatory parameters (MAP, CO, ScvO₂) does NOT guarantee adequate tissue perfusion.

Studies demonstrate:

Microcirculatory dysfunction persists despite macrocirculatory resuscitation
Microcirculatory parameters predict mortality independently of macrocirculation
Some patients with "normal" haemodynamics have severely impaired microcirculation
This explains persistent lactate elevation despite "adequate" resuscitation

The goal of resuscitation should extend beyond macrohemodynamics to microcirculatory perfusion (PMID: 17452929).

Mitochondrial Dysfunction

Cytopathic Hypoxia

"Cytopathic hypoxia" was coined by Fink to describe cellular inability to utilise oxygen despite adequate delivery (PMID: 12594860):

Clinical Note

Definition: Failure of cellular oxygen utilisation despite adequate tissue oxygen delivery

The Paradox:

Tissue PO₂ may be NORMAL or ELEVATED
Cells cannot oxidise substrates (pyruvate)
Aerobic glycolysis increases (Warburg effect)
Lactate rises despite adequate DO₂
ScvO₂ may be ELEVATED (oxygen not extracted)

Clinical implication: Simply increasing oxygen delivery does not correct the problem

Mechanisms of Mitochondrial Dysfunction

1. Nitric Oxide (NO) Inhibition

iNOS upregulated in MODS → excessive NO production
NO competitively inhibits Complex IV (cytochrome c oxidase)
Reversible at low levels; persistent at high levels
Peroxynitrite (NO + superoxide) causes irreversible damage (PMID: 12133656)

2. Oxidative and Nitrosative Stress

Target	Damage Mechanism	Consequence
mtDNA	Oxidative base damage	Impaired protein synthesis
Cardiolipin	Lipid peroxidation	Cytochrome c release, MPTP opening
ETC complexes	Protein oxidation/nitration	Electron transport failure
Fe-S clusters	Oxidative damage	Enzyme inactivation

3. Metabolic Reprogramming

Shift from oxidative phosphorylation to aerobic glycolysis (Warburg effect)
Reduced pyruvate oxidation despite adequate oxygen
Lactate accumulates as glycolytic end-product
ATP production falls (2 vs 36 ATP per glucose)

4. Mitochondrial Permeability Transition (MPT)

Calcium overload triggers MPT pore opening
Loss of mitochondrial membrane potential
Cytochrome c release → apoptosis pathway
ATP depletion → necrosis pathway

Bioenergetic Failure

Consequences of ATP depletion:

ATP-Dependent Process	Failure Consequence
Na⁺-K⁺-ATPase	Cell swelling, depolarisation
Ca²⁺-ATPase	Calcium overload, enzyme activation
Protein synthesis	Loss of cellular function
DNA repair	Accumulation of damage
Muscle contraction	Respiratory muscle weakness

The Cellular Hibernation Hypothesis

Concept

The cellular hibernation hypothesis, proposed by Brealey and Singer, explains the "MODS paradox"

why organs fail functionally despite minimal histological damage (PMID: 12225604):

Clinical Note

Hypothesis: Cells deliberately downregulate energy-consuming processes to survive the metabolic crisis of critical illness

Evidence:

Organs fail clinically but show minimal cell death at autopsy
Mitochondrial function correlates with illness severity
Survivors show mitochondrial biogenesis (recovery of function)
Non-survivors show persistent mitochondrial dysfunction

Mechanisms:

Reduced protein synthesis (energy conservation)
Downregulated ion pumps (reduced ATP consumption)
Decreased contractility (myocardial hibernation)
Reduced solute transport (tubular stunning)

Clinical Implication: Organ dysfunction is potentially REVERSIBLE if the patient survives the acute phase

Adaptive vs Maladaptive Responses

Adaptive Response	Maladaptive Response
Metabolic shutdown preserves cell viability	Prolonged shutdown leads to organ dysfunction
Mitochondrial biogenesis enables recovery	Failure of biogenesis leads to death
Temporary function loss, structure preserved	Transition to irreversible cell death
Recovery possible with time	PICS, chronic critical illness

Evidence for Hibernation

Minimal histological damage: Autopsy shows surprisingly mild changes despite profound dysfunction
Reversibility: Cardiac, renal function often recovers completely
Mitochondrial correlation: Mitochondrial function correlates with severity and recovery (PMID: 12133656)
Biogenesis markers: Survivors upregulate PGC-1α, TFAM
Metabolic adaptation: Cells switch to lower-energy states

Immune Dysregulation: SIRS → CARS → PICS

Temporal Evolution of Immune Response

The immune response in MODS evolves through distinct phases (PMID: 22710073):

INSULT
   ↓
SIRS (Systemic Inflammatory Response Syndrome)
- Hours to days 1-3
- Pro-inflammatory cytokine surge (TNF-α, IL-1β, IL-6)
- Hyperinflammation, fever, vasodilatation
- Risk: Cytokine storm, early MODS, early death
   ↓
CARS (Compensatory Anti-inflammatory Response Syndrome)
- Days 3-7+
- Anti-inflammatory predominance (IL-10, TGF-β)
- Immunoparalysis, anergy
- Risk: Secondary infections, late death
   ↓
MARS (Mixed Antagonist Response Syndrome)
- Variable timing
- Simultaneous SIRS and CARS
- Most patients have features of both
   ↓
Resolution                    OR                    PICS
(Recovery)                                 (Persistent Inflammation-
                                           Immunosuppression-Catabolism
                                           Syndrome)

Persistent Inflammation-Immunosuppression-Catabolism Syndrome (PICS)

Clinical Note

Definition: A syndrome of ongoing:

Persistent inflammation (elevated CRP, low-grade cytokine elevation)
Immunosuppression (lymphopenia, reduced HLA-DR, secondary infections)
Catabolism (muscle wasting, negative nitrogen balance, poor wound healing)

Characteristics:

Develops in patients who survive initial insult
ICU length of stay >14 days
Persistent organ dysfunction
Recurrent infections
Failure to wean from mechanical ventilation
Profound muscle wasting (sarcopenia)

Outcomes:

Prolonged hospitalisation
Discharge to long-term care facility
Poor quality of life
Increased 1-year mortality
Chronic critical illness (CCI)

Biomarkers of Immune State

Phase	Pro-inflammatory	Anti-inflammatory	Other
SIRS	↑↑↑ TNF-α, IL-1β, IL-6	↑ IL-10	High CRP
CARS	↓ TNF-α, IL-1β	↑↑ IL-10	Low mHLA-DR (<30%)
PICS	↑ (persistent)	↑ (persistent)	Lymphopenia, ↑ MDSCs

Chronic Critical Illness (CCI)

Definition: ICU LOS ≥14 days with persistent organ dysfunction

Epidemiology:

5-10% of ICU admissions
Increasing prevalence (improved acute survival)
Accounts for 30-50% of ICU bed-days

Characteristics:

PICS phenotype
Recurrent infectious complications
Failure to wean from mechanical ventilation
Persistent inflammation (CRP >3 mg/L)
Lymphopenia and immunosuppression
Protein-calorie malnutrition
Neuroendocrine dysfunction
Cognitive impairment

Outcomes (PMID: 22710073):

1-year mortality: 30-50%
<50% return home
Significant long-term disability
Poor quality of life

Individual Organ Failure Pathology

Respiratory Failure (ARDS)

Clinical Note

Definition: Acute onset bilateral pulmonary infiltrates, PaO₂/FiO₂ ≤300, not explained by cardiac failure (Berlin Definition) (PMID: 22797452)

Histopathology - Diffuse Alveolar Damage (DAD):

Phase	Timing	Features
Exudative	Days 0-7	Alveolar oedema, haemorrhage, hyaline membranes, neutrophil infiltration
Proliferative	Days 7-21	Type II pneumocyte hyperplasia, fibroblast proliferation, early fibrosis
Fibrotic	>21 days	Collagen deposition, architectural distortion (some patients)

Mechanisms in MODS:

Indirect ARDS more common than direct
Gut-derived mediators reach lungs via mesenteric lymph
Circulating cytokines prime pulmonary endothelium
Neutrophil sequestration in pulmonary capillaries
Glycocalyx degradation → alveolar-capillary leak
Surfactant dysfunction (Type II cell injury)

Cardiovascular Dysfunction

Sepsis-Induced Cardiomyopathy (SIC):

Feature	Description
Pattern	Biventricular dilation, reduced EF (may be preserved)
Reversibility	Usually resolves in 7-10 days
Histology	Minimal: myofibrillar oedema, focal contraction band necrosis
Mechanisms	Circulating myocardial depressant factors (TNF-α, IL-1β), excessive NO → reduced β-adrenergic responsiveness, mitochondrial dysfunction, calcium handling abnormalities
Troponin	Commonly elevated; reflects myocardial stress, not always ischaemia

Vasoplegia:

Profound vasodilation refractory to catecholamines
Mechanisms: excessive NO (iNOS), reduced α-receptor sensitivity, ATP-sensitive K⁺ channel opening
Contributes to distributive shock

Acute Kidney Injury (AKI)

Clinical Note

Incidence: 40-50% of MODS patients

Histopathology (paradoxically mild):

Focal acute tubular injury (NOT widespread necrosis)
Loss of brush border microvilli
Tubular epithelial vacuolisation
Mild interstitial oedema
Fibrin thrombi (if DIC present)

Pathophysiology (PMID: 26537049):

Microcirculatory dysfunction: Heterogeneous flow, shunting (can occur with NORMAL total RBF)
Inflammation: TLR4 activation on tubular cells by PAMPs/DAMPs
Mitochondrial dysfunction: Metabolic reprogramming
Tubular stunning: Deliberate downregulation of solute transport to conserve energy

Key insight: SA-AKI can occur despite normal or HIGH renal blood flow - it is not primarily ischaemic

Hepatic Dysfunction

Pattern	Mechanism	Clinical Features
Ischaemic hepatitis ("Shock liver")	Centrilobular necrosis from hypoperfusion	AST/ALT markedly elevated (thousands), rapid rise and fall
Sepsis-associated cholestasis	Bilirubin transporter downregulation (BSEP, MRP2)	Conjugated hyperbilirubinaemia, mild enzyme elevation
Kupffer cell activation	Cytokine and ROS production	Contributes to systemic inflammation

Hepatic dysfunction impacts:

Reduced drug metabolism (CYP450 dysfunction)
Reduced protein synthesis (albumin, clotting factors)
Impaired lactate clearance (Cori cycle)
Reduced endotoxin clearance

Neurological Dysfunction (SAE)

Sepsis-Associated Encephalopathy (SAE):

Aspect	Details
Incidence	50-70% of septic patients
Clinical	Spectrum from confusion/delirium to coma
Risk factors	Age, pre-existing cognitive impairment, illness severity
Mechanisms	BBB disruption, neuroinflammation (microglial activation), neurotransmitter imbalance, impaired cerebral autoregulation, oxidative stress
Histopathology	Microglial activation, perivascular oedema, ischaemic neurons ("red neurons")
Long-term	Cognitive impairment in 20-40% of survivors

Haematological Dysfunction (DIC)

Disseminated Intravascular Coagulation (DIC):

Feature	Mechanism
Coagulation activation	Tissue factor expression → thrombin generation
Anticoagulant depletion	Antithrombin consumption, impaired Protein C activation
Fibrinolysis inhibition	PAI-1 upregulation
NETosis	NET scaffold promotes thrombosis
Clinical	Bleeding + organ ischaemia (paradoxical)

ISTH DIC Score for diagnosis (PMID: 31327219)

Recovery and Long-Term Outcomes

Determinants of Recovery

Factors favouring recovery:

Younger age
Fewer pre-existing comorbidities
Lower initial SOFA score
Early SOFA improvement
Successful mitochondrial biogenesis
Resolution of inflammatory state
Adequate nutritional support

Mitochondrial Biogenesis

Recovery from MODS requires generation of new, functional mitochondria (PMID: 17245130):

Key players:

PGC-1α: Master regulator of mitochondrial biogenesis
NRF-1, NRF-2: Transcription factors for mitochondrial genes
TFAM: Mitochondrial transcription factor A (mtDNA replication)
Mitophagy: Clearance of damaged mitochondria (quality control)

Survivors vs non-survivors:

Survivors show early upregulation of biogenesis markers
Non-survivors have persistent mitochondrial dysfunction
Therapeutic strategies targeting biogenesis under investigation

Long-Term Outcomes After MODS

Clinical Note

Physical impairment:

ICU-acquired weakness (25-50%)
Persistent respiratory dysfunction
Chronic kidney disease
Cardiac dysfunction

Cognitive impairment:

Executive dysfunction (30-50%)
Memory deficits
Attention problems
PTSD (20-30%)

Quality of life:

Reduced physical function
Reduced social participation
Dependence on caregivers
Financial impact

Mortality:

1-year mortality 20-40% higher than matched controls
5-year mortality significantly elevated

Post-Intensive Care Syndrome (PICS-Patient)

Not to be confused with PICS (Persistent Inflammation-Immunosuppression-Catabolism Syndrome), PICS-Patient refers to Post-Intensive Care Syndrome affecting ICU survivors:

Domain	Manifestations
Physical	ICU-acquired weakness, fatigue, reduced exercise capacity
Cognitive	Memory, attention, executive function deficits
Mental health	Depression, anxiety, PTSD
Social	Reduced participation, relationship strain

Prognostication in MODS

Scoring Systems

SOFA Score Trends

Delta SOFA: Change over 48-72 hours more predictive than absolute value
SOFA improvement: >2-point reduction predicts survival
SOFA deterioration: Increasing score predicts mortality

APACHE II/III/IV

APACHE (Acute Physiology and Chronic Health Evaluation):

Originally developed for ICU prognostication
Includes physiological derangements + age + chronic health
APACHE IV is current version (customised to diagnosis)

ANZROD

Australian and New Zealand Risk of Death model (PMID: 25078899):

Developed from ANZICS-CORE database
Better calibrated for ANZ population than APACHE
Includes diagnostic category-specific coefficients

Biomarkers for Prognostication

Biomarker	Role in MODS
Lactate	Reflects tissue hypoperfusion; clearance predicts outcome
Procalcitonin	Bacterial infection; guides antibiotic therapy; trends useful
CRP	Non-specific inflammation; trends more useful than absolute
Presepsin	Early marker; rises quickly
MR-proADM	Best predictor of organ failure and mortality
IL-6	Correlates with severity; research use
mHLA-DR	Immunoparalysis; <30% predicts secondary infections

Lactate as Prognostic Marker

Clinical Pearl

Initial lactate:

4 mmol/L: Mortality >30%
8 mmol/L: Mortality >60%

Lactate clearance (more useful than absolute):

Clearance >10-20% in 2-6 hours: Better prognosis
Non-clearance or rising lactate: Poor prognosis

Causes of persistent lactate in MODS:

Ongoing tissue hypoperfusion (Type A)
Mitochondrial dysfunction (Type B - cytopathic hypoxia)
Reduced hepatic clearance
Catecholamine-stimulated glycolysis

Australian/New Zealand Context

MODS Epidemiology in Australia/NZ

Clinical Note

ANZICS-CORE Database:

Largest binational critical care database
2 million ICU admissions
Benchmarks outcomes across ANZ ICUs

MODS Statistics:

Sepsis-related MODS: ~15,000 cases/year in Australia
ICU mortality for MODS: Variable by organ number (20% single → >70% ≥3 organs)
Hospital mortality higher than ICU mortality (ongoing deaths)

Improving outcomes:

Standardised care bundles
Early recognition programs
Quality improvement initiatives

ANZROD Model

The Australian and New Zealand Risk of Death (ANZROD) model provides locally calibrated mortality prediction:

Developed from ANZICS-CORE data
Updated regularly
Better discrimination than APACHE for ANZ population
Used for benchmarking and quality improvement

Indigenous Health Considerations

Indigenous Health Context

Aboriginal and Torres Strait Islander Peoples

Epidemiological Burden:

Higher rates of sepsis and MODS-related admissions
Younger age at presentation (median 15-20 years younger)
Higher illness severity scores at admission
Higher ICU and hospital mortality even after adjustment
Over-representation in prolonged ICU stays

Risk Factors:

Higher prevalence of chronic diseases predisposing to MODS:
- Rheumatic heart disease
- Chronic kidney disease/ESKD
- Diabetes mellitus
- Chronic lung disease (bronchiectasis)
Reduced access to primary healthcare
Later presentation due to barriers
Socioeconomic disadvantage
Remote/rural residence

Healthcare System Considerations:

Need for culturally safe ICU care
Importance of Aboriginal Health Workers (AHWs) and Aboriginal Liaison Officers (ALOs)
Family/community involvement in decision-making
Interpreter services where needed
Different explanatory models of illness
Challenges with discharge planning, especially to remote communities
Risk of under-triage in emergency settings

Closing the Gap:

Improving critical illness outcomes is integral to closing the life expectancy gap
Early recognition of deterioration programs must be culturally appropriate
Community health education needed

Māori Health (New Zealand)

Epidemiological Burden:

Higher rates of sepsis and MODS
Younger age at presentation
Higher prevalence of predisposing conditions

Cultural Considerations:

Whānau (extended family) central to decision-making
Kaumātua (elders) involvement in serious discussions
Tikanga Māori (cultural practices) in healthcare
Te reo Māori (Māori language) services
Te Whare Tapa Whā (holistic Māori health model)
Māori Health Workers involvement

Te Tiriti o Waitangi:

Healthcare obligations under the Treaty
Ensuring equitable outcomes
Partnership principles in care delivery

SAQ Practice Questions

Clinical Note

Question: Describe the pathophysiology of Multi-Organ Dysfunction Syndrome (MODS), including the role of the gut hypothesis and organ cross-talk. (15 marks)

Model Answer

1. Definition and Classification (2 marks)

MODS is defined as the development of potentially reversible physiological dysfunction in two or more organ systems arising from an acute threat to systemic homeostasis.

This patient has secondary MODS - organ dysfunction developing as a consequence of the host inflammatory response to the initial insult (peritonitis), rather than direct injury to the failing organs.

2. Initiating Events and Systemic Inflammation (3 marks)

Initial insult (peritonitis):

PAMPs released from intra-abdominal infection (LPS, peptidoglycan)
DAMPs from tissue damage (HMGB1, mitochondrial DNA, ATP)
Pattern recognition receptor activation (TLR4, TLR2, TLR9)

Inflammatory cascade:

NF-κB activation → pro-inflammatory cytokine production
TNF-α (early, 30-90 min): endothelial activation, vasodilation, fever
IL-1β: synergistic with TNF-α, neutrophil activation
IL-6: acute phase response, correlates with severity

Two-hit phenomenon: Surgery provides second hit to already primed inflammatory system, amplifying response.

3. The Gut Hypothesis (4 marks)

The gut is proposed as the "motor" of MODS:

Intestinal barrier failure in critical illness:

Splanchnic hypoperfusion during shock
Enterocyte apoptosis (TNF-α, Fas/FasL)
Tight junction disruption (claudin, occludin dysfunction)
Mucus layer degradation
Dysbiosis (loss of beneficial flora, pathogen overgrowth)

Consequences of barrier failure:

Bacterial translocation (viable bacteria crossing to sterile tissues)
PAMP release (LPS, peptidoglycan) into portal and systemic circulation
DAMP release from damaged enterocytes

Key concept - Gut-lymph hypothesis:

Mesenteric lymph (not portal blood) is primary route of gut-derived factors to systemic circulation
Lymph bypasses hepatic clearance
Reaches pulmonary circulation directly via thoracic duct
Explains ARDS development (lung as first capillary bed exposed)

4. Organ Cross-Talk (3 marks)

Organ cross-talk describes bidirectional communication whereby dysfunction in one organ propagates to distant organs:

Gut-Lung Axis:

Intestinal inflammation primes pulmonary neutrophils
Mesenteric lymph carries cytokines/PAMPs to lungs
Results in ARDS (as seen in this patient)

Cardiorenal Syndrome:

Cardiac dysfunction → renal venous congestion → AKI
AKI → fluid overload → cardiac strain
Neurohormonal activation (RAAS, SNS) affects both organs

Hepatorenal Interaction:

Liver dysfunction reduces endotoxin clearance → systemic inflammation
Portal hypertension → splanchnic vasodilation → renal hypoperfusion

5. Endothelial and Microcirculatory Failure (2 marks)

Endothelial glycocalyx degradation:

Sheddases (heparanase, MMPs) activated by cytokines
Consequences: capillary leak, leukocyte adhesion, microthrombosis

Microcirculatory dysfunction:

Heterogeneous capillary flow (some ischaemic, some hyperaemic)
Reduced functional capillary density
Impaired oxygen extraction despite adequate macrocirculation
Explains persistent lactate despite normalised MAP/CO

6. Clinical Correlation (1 mark)

In this patient:

Hypoxemia: ARDS from gut-lung axis activation
Oliguria: SA-AKI from inflammation, microcirculatory dysfunction
Hyperbilirubinaemia: Cholestasis from transporter downregulation, Kupffer cell activation

Clinical Note

Question: Describe the immunological changes that occur following sepsis, including the concepts of immunoparalysis and PICS. Explain how these contribute to late morbidity and mortality. (15 marks)

Model Answer

1. Temporal Evolution of Immune Response (3 marks)

Early phase (SIRS) - Days 0-3:

Hyperinflammatory state
Pro-inflammatory cytokine surge (TNF-α, IL-1β, IL-6)
Systemic effects: fever, vasodilation, capillary leak
Risk: Cytokine storm, early MODS

Compensatory phase (CARS) - Days 3-7+:

Anti-inflammatory response predominates
IL-10, TGF-β elevation
Immunosuppression develops
Risk: Secondary infections

Mixed phase (MARS):

Concurrent pro- and anti-inflammatory features
Most patients have features of both

2. Immunoparalysis - Cellular Mechanisms (4 marks)

Lymphocyte apoptosis (Hotchkiss):

Massive programmed cell death of CD4+ T cells, CD8+ T cells, B cells, dendritic cells
Mechanisms: Extrinsic (Fas/FasL), intrinsic (mitochondrial), glucocorticoid-induced
Regulatory T cells (Tregs) relatively spared → immunosuppressive bias
Result: Lymphopenia (as seen in this patient)

Monocyte/macrophage dysfunction:

HLA-DR downregulation (<30% = immunoparalysis)
Impaired antigen presentation
Reduced cytokine production capacity ("endotoxin tolerance")
Clinical threshold: <8,000 Ab/cell or <30% HLA-DR+ monocytes

Immune checkpoint upregulation:

Increased PD-1 on T cells
Increased PD-L1 on monocytes
T cell anergy and exhaustion (similar to chronic infections, cancer)

Myeloid-derived suppressor cell expansion:

Immature myeloid cells with immunosuppressive function
Contribute to T cell dysfunction

3. PICS - Persistent Inflammation-Immunosuppression-Catabolism Syndrome (3 marks)

PICS represents the final common pathway in patients who survive initial sepsis but fail to recover:

Persistent inflammation:

Ongoing low-grade inflammation (CRP elevated, cytokines)
Failure to resolve inflammatory response
Contributes to ongoing organ dysfunction

Immunosuppression:

Persistent lymphopenia
Low HLA-DR
Susceptibility to opportunistic infections (as in this patient - Candida)
Recurrent bacterial infections

Catabolism:

Profound muscle wasting (sarcopenia)
Negative nitrogen balance
Poor wound healing
Failure to wean from mechanical ventilation

4. Clinical Consequences in This Patient (3 marks)

Secondary infection (Candida):

Direct consequence of immunoparalysis
Impaired antigen presentation, lymphocyte function
Candida bloodstream infections carry 30-40% mortality
Common in prolonged ICU stay with immunosuppression

Ventilator dependence:

Respiratory muscle wasting (catabolism)
Persistent lung injury (ongoing inflammation)
ICU-acquired weakness
Contributes to chronic critical illness

Chronic Critical Illness (CCI):

ICU LOS >14 days with persistent organ dysfunction
PICS phenotype
Poor long-term outcomes

5. Long-Term Outcomes (2 marks)

In-hospital:

Prolonged ICU and hospital stay
Recurrent infections
High resource utilisation

Post-discharge:

1-year mortality 30-50% in CCI
<50% return home
Cognitive impairment (20-40%)
Physical disability (ICU-acquired weakness)
Reduced quality of life
PTSD, depression, anxiety

Viva Scenarios

Viva Scenario

Examiner Introduction

"A 45-year-old man develops MODS following severe necrotising pancreatitis. I'd like to explore the pathophysiology of multi-organ dysfunction."

Examiner: What is MODS and how would you classify it?

Candidate: MODS is defined as the development of potentially reversible physiological dysfunction in two or more organ systems arising from an acute threat to systemic homeostasis.

It can be classified as:

Primary MODS: Direct insult to the failing organ(s)

Example: ARDS from pulmonary contusion

Secondary MODS: Results from the host inflammatory response to an insult, affecting organs not directly injured

Example: ARDS developing after pancreatitis, as in this case

This patient would have secondary MODS - his lungs, kidneys, and other organs fail as a consequence of the systemic inflammatory response to pancreatitis, not direct pancreatic injury to those organs.

Examiner: How does the SOFA score quantify organ dysfunction?

Candidate: The Sequential Organ Failure Assessment score evaluates six organ systems:

Respiratory: PaO₂/FiO₂ ratio (≥400 = 0, <100 with support = 4)
Coagulation: Platelet count (≥150 = 0, <20 = 4)
Hepatic: Bilirubin (normal = 0, >204 μmol/L = 4)
Cardiovascular: MAP and vasopressor requirements
Neurological: GCS (15 = 0, <6 = 4)
Renal: Creatinine and urine output

Each system scores 0-4, giving a maximum of 24.

Prognostic value:

Each 1-point increase is associated with approximately 10% increase in mortality
SOFA ≥2 increase defines organ dysfunction in Sepsis-3
Delta SOFA (change over time) is more predictive than absolute value
Non-improvement at 48-72 hours predicts poor outcome

Examiner: Explain the concept of organ cross-talk in MODS.

Candidate: Organ cross-talk refers to bidirectional communication between organ systems whereby dysfunction in one organ propagates to cause or worsen dysfunction in distant organs.

This occurs through:

Humoral mediators (cytokines, hormones)
Immune cell trafficking
Neural pathways (autonomic)
Haemodynamic effects
Microvesicles/exosomes

Examples relevant to pancreatitis:

Gut-Lung Axis:

Pancreatitis causes intestinal hypoperfusion
Intestinal barrier failure leads to bacterial translocation
Gut-derived factors travel via mesenteric lymph to pulmonary circulation
Results in ARDS (very common in severe pancreatitis)

Pancreatic-Renal:

Pancreatic necrosis releases pro-inflammatory mediators
Systemic inflammation causes renal microcirculatory dysfunction
Intra-abdominal hypertension from fluid resuscitation → AKI

Cardiorenal Syndrome:

Fluid resuscitation → cardiac strain
Cardiac dysfunction → renal venous congestion
Renal failure → fluid overload → worsening cardiac function

Examiner: What is the gut hypothesis?

Candidate: The gut hypothesis, proposed by Meakins and Marshall in 1986, posits that the gastrointestinal tract is the "motor" of MODS.

Key concepts:

The gut as a unique organ:

Largest immune organ (70-80% of immune cells)
Massive cytokine production capacity
Barrier separating 10^14 bacteria from sterile body
Reservoir of PAMPs (LPS, peptidoglycan)

Barrier failure in critical illness:

Splanchnic hypoperfusion
Enterocyte apoptosis
Tight junction disruption
Mucus layer degradation
Dysbiosis (loss of beneficial flora)

Consequences:

Bacterial translocation
PAMP release (LPS, peptidoglycan)
DAMP release from damaged enterocytes
Perpetuation of systemic inflammation

The gut-lymph hypothesis (important refinement):

Mesenteric lymph, not portal blood, is the primary route
Lymph bypasses hepatic clearance (Kupffer cells)
Reaches pulmonary circulation directly via thoracic duct
This explains ARDS development and why liver failure doesn't protect from gut-derived MODS

Examiner: How does microcirculatory dysfunction contribute to MODS?

Candidate: Microcirculatory dysfunction is a key pathophysiological feature of MODS:

Normal microcirculation:

Homogeneous capillary flow
Functional capillary density ~10-12 mm/mm²
Continuous RBC flow enabling oxygen delivery

Abnormalities in MODS:

Heterogeneous flow distribution:
- Some capillaries have high flow (hyperaemic)
- Adjacent capillaries have low/no flow (ischaemic)
- Creates functional shunting
Reduced functional capillary density:
- Often <6 mm/mm² in MODS
- Increased oxygen diffusion distance
Increased stopped-flow capillaries:
- Normal: <5%
- MODS: >20-40%

Mechanisms:

Endothelial dysfunction and glycocalyx loss
Microthrombosis (DIC)
Reduced RBC deformability
Leukocyte adhesion blocking capillaries
Tissue oedema

Clinical significance:

Macrocirculation-microcirculation dissociation
Normal MAP, CO, ScvO₂ does NOT guarantee tissue perfusion
Explains persistent lactate despite "adequate" resuscitation
Microcirculatory parameters predict mortality independently

Examiner: Excellent discussion. Any questions?

Candidate: No, thank you.

Viva Scenario

Examiner Introduction

"A patient with MODS has persistent lactate elevation despite normalized hemodynamics. Let's discuss mitochondrial dysfunction and recovery from MODS."

Examiner: What is cytopathic hypoxia?

Candidate: Cytopathic hypoxia is a term coined by Fink to describe the cellular inability to utilise oxygen despite adequate delivery.

Key features:

Tissue PO₂ may be normal or even elevated
Cells cannot oxidise substrates (pyruvate)
Aerobic glycolysis increases (Warburg effect)
Lactate rises despite adequate DO₂
ScvO₂ may be elevated (oxygen not extracted)

This explains why this patient has persistent hyperlactataemia despite normalised macrocirculation - the problem is at the cellular level, not oxygen delivery.

Examiner: What are the mechanisms of mitochondrial dysfunction in MODS?

Candidate: There are several interconnected mechanisms:

1. Nitric oxide (NO) inhibition:

iNOS massively upregulated in MODS
NO competitively inhibits Complex IV (cytochrome c oxidase)
Reversible at low levels; persistent at high levels
Peroxynitrite (NO + superoxide) causes irreversible damage

2. Oxidative and nitrosative stress:

Targets include:
- mtDNA (oxidative base damage)
- Cardiolipin (lipid peroxidation → cytochrome c release)
- ETC complexes (protein oxidation/nitration)
- Fe-S clusters

3. Metabolic reprogramming:

Shift from oxidative phosphorylation to aerobic glycolysis
Reduced pyruvate oxidation despite adequate oxygen
ATP yield falls: 2 ATP vs 36 ATP per glucose

4. Mitochondrial Permeability Transition:

Calcium overload triggers MPT pore opening
Loss of mitochondrial membrane potential
Cytochrome c release → apoptosis
Severe cases → necrosis

Examiner: What is the cellular hibernation hypothesis?

Candidate: The cellular hibernation hypothesis, proposed by Brealey and Singer, explains the "MODS paradox"

why organs fail functionally despite minimal histological damage.

Concept:

Cells deliberately downregulate energy-consuming processes to survive the metabolic crisis
This is an adaptive response to bioenergetic failure

Evidence:

Minimal histological damage: Autopsy studies show surprisingly mild changes despite profound clinical dysfunction
Reversibility: Cardiac, renal function often recover completely
Mitochondrial correlation: Mitochondrial function correlates with severity and recovery
Biogenesis markers: Survivors upregulate PGC-1α, TFAM

Mechanisms of hibernation:

Reduced protein synthesis (energy conservation)
Downregulated ion pumps
Decreased contractility (myocardial hibernation)
Reduced solute transport (tubular stunning)

Clinical implication: Organ dysfunction is potentially REVERSIBLE if the patient survives the acute phase.

Examiner: What determines recovery vs progression to chronic critical illness?

Candidate: Recovery depends on several factors:

Favourable factors:

Younger age
Fewer comorbidities
Lower initial SOFA score
Early SOFA improvement (>2 points in 48-72h)
Successful resolution of inflammation
Adequate nutritional support

Critical for recovery - Mitochondrial biogenesis:

Generation of new, functional mitochondria
Key regulators:
- "PGC-1α: Master regulator"
- "NRF-1, NRF-2: Transcription factors"
- "TFAM: mtDNA replication"
Mitophagy: Clearance of damaged mitochondria

Survivors vs non-survivors:

Survivors show early upregulation of biogenesis markers
Non-survivors have persistent mitochondrial dysfunction

Progression to PICS/CCI occurs when:

Persistent inflammation (CRP elevated, cytokines)
Immunosuppression (lymphopenia, low HLA-DR)
Catabolism (muscle wasting, negative nitrogen balance)
Failure of mitochondrial recovery
Recurrent infections

Examiner: What is PICS and how does it affect long-term outcomes?

Candidate: PICS is Persistent Inflammation-Immunosuppression-Catabolism Syndrome, representing the final common pathway in patients who survive initial critical illness but fail to recover.

Three components:

1. Persistent inflammation:

Ongoing low-grade inflammation
Elevated CRP (typically >3 mg/L)
Low-grade cytokine elevation
Contributes to ongoing organ dysfunction

2. Immunosuppression:

Persistent lymphopenia
Low monocyte HLA-DR expression
High susceptibility to secondary infections
Recurrent sepsis episodes

3. Catabolism:

Profound muscle wasting (sarcopenia)
Negative nitrogen balance
Poor wound healing
Failure to wean from mechanical ventilation

Clinical features of PICS:

ICU LOS typically >14 days
Persistent organ dysfunction
Ventilator dependence
Recurrent infections
Functional decline

Long-term outcomes:

1-year mortality: 30-50%
<50% return home
Significant physical disability (ICU-acquired weakness)
Cognitive impairment (20-40%)
Depression, anxiety, PTSD
Poor quality of life
High healthcare utilisation

This represents a major public health burden as more patients survive initial critical illness.

Examiner: Very comprehensive. Thank you.

Candidate: Thank you.

MCQ Practice Questions

Clinical Note

ZROD model?" back="Australian and New Zealand Risk of Death model. Developed from ANZICS-CORE database. Better calibrated for ANZ population than APACHE. Used for ICU mortality prediction, benchmarking, and quality improvement." tags= />

References

Landmark Papers

Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. ACCP/SCCM Consensus Conference Committee. Chest. 1992;101(6):1644-1655. PMID: 1597163
Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med. 1996;22(7):707-710. PMID: 8844239
Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-810. PMID: 26903338
Gentile LF, Cuenca AG, Efron PA, et al. Persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive care. J Trauma Acute Care Surg. 2012;72(6):1491-1501. PMID: 22710073

Gut Hypothesis and Organ Cross-Talk

Meakins JL, Marshall JC. The gut as the motor of multiple system organ failure. In: Marston A, Bulkley GB, Fiddian-Green RG, Haglund U, eds. Splanchnic Ischaemia and Multiple Organ Failure. London: Edward Arnold; 1989:339-348.
Deitch EA. Gut-origin sepsis: evolution of a concept. Surgeon. 2012;10(6):350-356. PMID: 22940066
Deitch EA. Gut lymph and lymphatics: a source of factors leading to organ injury and dysfunction. Ann N Y Acad Sci. 2010;1207 Suppl 1:E103-E111. PMID: 20961312
Magnotti LJ, Deitch EA. Burns, bacterial translocation, gut barrier function, and failure. J Burn Care Rehabil. 2005;26(5):383-391. PMID: 16151282
Deitch EA, Xu D, Kaise VL. Role of the gut in the development of injury- and shock induced SIRS and MODS: the gut-lymph hypothesis, a review. Front Biosci. 2006;11:520-528. PMID: 16146749
Ronco C, Haapio M, House AA, et al. Cardiorenal syndrome. J Am Coll Cardiol. 2008;52(19):1527-1539. PMID: 18802999
Mao H, Katz N, Ariyanon W, et al. Cardiac surgery-associated acute kidney injury. Cardiorenal Med. 2013;3(3):178-199. PMID: 24454315
Adebayo D, Morabito V, Davenport A, Jalan R. Renal dysfunction in cirrhosis is not just a vasomotor nephropathy. Kidney Int. 2015;87(3):509-515. PMID: 25229334

Endothelium and Microcirculation

Uchimido R, Schmidt EP, Bhind AH. The glycocalyx: a novel diagnostic and therapeutic target in sepsis. Crit Care. 2019;23(1):16. PMID: 30654825
De Backer D, Donadello K, Sakr Y, et al. Microcirculatory alterations in patients with severe sepsis: impact of time of assessment and relationship with outcome. Crit Care Med. 2013;41(3):791-799. PMID: 23318492
Ince C. The microcirculation is the motor of sepsis. Crit Care. 2005;9 Suppl 4(Suppl 4):S13-S19. PMID: 16168069
De Backer D, Creteur J, Preiser JC, et al. Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med. 2002;166(1):98-104. PMID: 12091178
Sakr Y, Dubois MJ, De Backer D, et al. Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med. 2004;32(9):1825-1831. PMID: 15343008

Mitochondrial Dysfunction

Fink MP. Cytopathic hypoxia: Mitochondrial dysfunction as mechanism contributing to organ dysfunction in sepsis. Crit Care Clin. 2001;17(1):219-237. PMID: 11219231
Brealey D, Brand M, Hargreaves I, et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet. 2002;360(9328):219-223. PMID: 12133656
Brealey D, Singer M. Mitochondrial dysfunction in sepsis. Curr Infect Dis Rep. 2003;5(5):365-371. PMID: 12484668
Carré JE, Orber M, Hailey RJ, et al. Survival in critical illness is associated with early activation of mitochondrial biogenesis. Am J Respir Crit Care Med. 2010;182(6):745-751. PMID: 20538956
Singer M. Mitochondrial function in sepsis: acute phase versus multiple organ failure. Crit Care Med. 2007;35(9 Suppl):S441-S448. PMID: 17713394
Singer M. The role of mitochondrial dysfunction in sepsis-induced multi-organ failure. Virulence. 2014;5(1):66-72. PMID: 24185508

Immune Dysregulation

Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol. 2013;13(12):862-874. PMID: 24232462
Hotchkiss RS, Nicholson DW. Apoptosis and caspases regulate death and inflammation in sepsis. Nat Rev Immunol. 2006;6(11):813-822. PMID: 17039247
Hotchkiss RS, Swanson PE, Freeman BD, et al. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med. 1999;27(7):1230-1251. PMID: 10446814
Monneret G, Venet F, Pachot A, et al. Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony. Mol Med. 2008;14(1-2):64-78. PMID: 18026574
Venet F, Lukaszewicz AC, Payen D, et al. Monitoring the immune response in sepsis: a rational approach to administration of immunoadjuvant therapies. Curr Opin Immunol. 2013;25(4):477-483. PMID: 23725873

SOFA Score and Prognostication

Ferreira FL, Bota DP, Bross A, et al. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA. 2001;286(14):1754-1758. PMID: 11594901
de Grooth HJ, Geenen IL, Girbes AR, et al. SOFA and mortality endpoints in randomized controlled trials: a systematic review and meta-regression analysis. Crit Care. 2017;21(1):38. PMID: 28231816
Minne L, Abu-Hanna A, de Jonge E. Evaluation of SOFA-based models for predicting mortality in the ICU: A systematic review. Crit Care. 2008;12(6):R161. PMID: 19091120

ARDS and Organ-Specific Pathology

ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307(23):2526-2533. PMID: 22797452
Thompson BT, Chambers RC, Liu KD. Acute Respiratory Distress Syndrome. N Engl J Med. 2017;377(6):562-572. PMID: 28792873
Zarbock A, Gomez H, Kellum JA. Sepsis-induced acute kidney injury revisited: pathophysiology, prevention and future therapies. Curr Opin Crit Care. 2014;20(6):588-595. PMID: 25320909
Prowle JR, Bellomo R. Sepsis-associated acute kidney injury: macrohemodynamic and microhemodynamic alterations in the renal circulation. Semin Nephrol. 2015;35(1):64-74. PMID: 25795500
L'Heureux M, Sternberg M, Brath L, et al. Sepsis-Induced Cardiomyopathy: a Comprehensive Review. Curr Cardiol Rep. 2020;22(5):35. PMID: 32377972

Australian/NZ Context and ANZICS

Pilcher D, Paul E, Bailey M, Huckson S. The Australian and New Zealand Risk of Death (ANZROD) model: getting mortality prediction right for intensive care units. Crit Care Resusc. 2014;16(1):3-4. PMID: 24588429
Paul E, Bailey M, Pilcher D. Risk prediction of hospital mortality for adult patients admitted to Australian and New Zealand intensive care units: development and validation of the Australian and New Zealand Risk of Death model. J Crit Care. 2013;28(6):935-941. PMID: 24075293
Raith EP, Udy AA, Bailey M, et al. Prognostic Accuracy of the SOFA Score, SIRS Criteria, and qSOFA Score for In-Hospital Mortality Among Adults With Suspected Infection Admitted to the Intensive Care Unit. JAMA. 2017;317(3):290-300. PMID: 28114553

Indigenous Health

Jamieson L, Paradies Y, Gunthorpe W, et al. Oral health and social and emotional well-being in a birth cohort of Aboriginal Australian young adults. BMC Public Health. 2011;11:656. PMID: 21849087
Cass A, Cunningham J, Snelling P, et al. Exploring the pathways leading from disadvantage to end-stage renal disease for Indigenous Australians. Soc Sci Med. 2004;58(4):767-785. PMID: 14672593
Secombe PJ, Brown A, Kruger PS, Stewart PC. Lipid profiles and other factors in critically ill Aboriginal and Torres Strait Islander patients: a systematic review. Crit Care Resusc. 2019;21(1):6-17. PMID: 30857503

PICS and Chronic Critical Illness

Mira JC, Gentile LF, Mathias BJ, et al. Sepsis Pathophysiology, Chronic Critical Illness, and Persistent Inflammation-Immunosuppression and Catabolism Syndrome. Crit Care Med. 2017;45(2):253-262. PMID: 27632674
Stortz JA, Mira JC, Raymond SL, et al. Benchmarking clinical outcomes and the immunocatabolic phenotype of chronic critical illness after sepsis in surgical intensive care unit patients. J Trauma Acute Care Surg. 2018;84(2):342-349. PMID: 29251710
Needham DM, Davidson J, Cohen H, et al. Improving long-term outcomes after discharge from intensive care unit: report from a stakeholders' conference. Crit Care Med. 2012;40(2):502-509. PMID: 21946660

Additional Key References

Marshall JC, Cook DJ, Christou NV, et al. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med. 1995;23(10):1638-1652. PMID: 7587228
Baue AE. MOF, MODS, and SIRS: what is in a name or an acronym? Shock. 2006;26(5):438-449. PMID: 17047513
Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013;369(9):840-851. PMID: 23984731

Clinical board

Urgent signals

Exam focus

Editorial and exam context

Multi-Organ Dysfunction Syndrome (MODS) Pathology

Quick Answer

CICM Exam Focus

SAQ Topics (First Part Written)

Viva Topics

Common Examiner Questions

Key Points

Definition and Classification

Historical Evolution

Current Definition

Primary vs Secondary MODS

Two-Hit Hypothesis

The SOFA Score

Development and Validation

SOFA Score Components

SOFA Score Interpretation

Delta SOFA and Trends

Number of Failing Organs and Mortality

Pathophysiology Overview

Unifying Mechanisms

The Four Pillars of MODS Pathophysiology

Organ Cross-Talk

The Concept of Organ Cross-Talk

Gut-Lung Axis

Cardiorenal Syndrome

Hepatorenal Syndrome

Brain-Heart Interaction

Lung-Brain Axis

The Gut Hypothesis

Origins and Evolution

Mechanisms of Gut Barrier Failure

1. Epithelial Barrier

2. Immunological Barrier

3. Microbiological Barrier

Bacterial Translocation

PAMPs and Endotoxaemia

Clinical Evidence for Gut Hypothesis

Endothelial Activation and Dysfunction

The Endothelium as a Target and Effector Organ

Endothelial Glycocalyx

Glycocalyx Degradation in MODS

Consequences of Glycocalyx Degradation

Biomarkers of Glycocalyx Degradation

Adhesion Molecule Expression

Microcirculation in MODS

Normal Microcirculation

Microcirculatory Dysfunction in MODS

Mechanisms of Microcirculatory Dysfunction

Assessment of Microcirculation

Microcirculation-Macrocirculation Dissociation

Mitochondrial Dysfunction

Cytopathic Hypoxia

Mechanisms of Mitochondrial Dysfunction

1. Nitric Oxide (NO) Inhibition

2. Oxidative and Nitrosative Stress

3. Metabolic Reprogramming

4. Mitochondrial Permeability Transition (MPT)

Bioenergetic Failure

The Cellular Hibernation Hypothesis

Concept

Adaptive vs Maladaptive Responses

Evidence for Hibernation

Immune Dysregulation: SIRS → CARS → PICS

Temporal Evolution of Immune Response

Persistent Inflammation-Immunosuppression-Catabolism Syndrome (PICS)

Biomarkers of Immune State

Chronic Critical Illness (CCI)

Individual Organ Failure Pathology

Respiratory Failure (ARDS)

Cardiovascular Dysfunction

Acute Kidney Injury (AKI)

Hepatic Dysfunction

Neurological Dysfunction (SAE)

Haematological Dysfunction (DIC)

Recovery and Long-Term Outcomes

Determinants of Recovery